Impact of 30-Day Oral Dosing with N-acetyl-l-cysteine on Sprague-Dawley Rat Physiology

A number of studies have demonstrated a protective effect associated with N-acetyl-l-cysteine (NAC) against toxic chemical exposure. However, the impact of long-term oral dosing on tissue pathology has not been determined. In this study, the authors assessed the impact of long-term oral NAC administ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of toxicology 2004-07, Vol.23 (4), p.239-247
Hauptverfasser: Arfsten, Darryl P., Johnson, Eric W., Thitoff, Angie R., Jung, Anne E., Wilfong, Erin R., Lohrke, Scott M., Bausman, Tim A., Eggers, Jeffrey S., Bobb, Andrew J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 247
container_issue 4
container_start_page 239
container_title International journal of toxicology
container_volume 23
creator Arfsten, Darryl P.
Johnson, Eric W.
Thitoff, Angie R.
Jung, Anne E.
Wilfong, Erin R.
Lohrke, Scott M.
Bausman, Tim A.
Eggers, Jeffrey S.
Bobb, Andrew J.
description A number of studies have demonstrated a protective effect associated with N-acetyl-l-cysteine (NAC) against toxic chemical exposure. However, the impact of long-term oral dosing on tissue pathology has not been determined. In this study, the authors assessed the impact of long-term oral NAC administration on organ histopathology and tissue glutathione (GSH) and total glutathione-S-transferase (GST) activity levels in Sprague-Dawley (SD) rats. Groups of 20 SD rats (10 males, 10 females), 8 weeks of age, were dosed daily by oral gavage with deionized H2O (negative controls) or NAC solution at a rate of 600 or 1200 mg/kg/day for 30 days. Animals were euthanized 6 h after treatment on study day 30. There were no significant differences in final body weights or weekly average weight gain between treatment groups. Serum alanine amino-transferase (ALT) activities were significantly elevated (p ≤.05) in NAC-treated animals compared to controls when measured on study day 30. Histopathologic evaluation of the stomach, small intestine, liver, kidneys, spleen, thymus, and lungs revealed no lesions associated with NAC administration. When measured on study day 30, total GST activity for kidney and skin from NAC-treated animals were increased 39% to 131% as compared to controls. Tissue GSH concentrations from NAC-treated animals were increased 24% to 81% as compared with negative controls. Further studies are needed to determine if the observed increase in tissue GSH concentration and GST activity provide a degree of chemoprotection against dermal and systemic chemical toxicants.
doi_str_mv 10.1080/10915810490502041
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18055018</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1080_10915810490502041</sage_id><sourcerecordid>18055018</sourcerecordid><originalsourceid>FETCH-LOGICAL-c367t-a570400d1317a87a832d5fadf7fe1bd9e588eb585e9a222e7e0e6c398b35d7663</originalsourceid><addsrcrecordid>eNp9kM1Lw0AQxRdRrFb_AC-yJ29bZ5JudnOU1o9CseIX3sI2maQpSbZmE0r-e6MteBCEgRmG33vwHmMXCCMEDdcIIUqNMA5BggdjPGAn_c8TWo0_Dn9uFD2gB-zUuTUABEriMRug9BVioE_Y-6zcmLjhNuU-iKnp-KI2BZ9al1cZ3-bNij8KE1PTFaIQcecayivituIvm9pkLfWabUEdfzYNf1p1LreFzbozdpSawtH5fg_Z293t6-RBzBf3s8nNXMR-oBphpIIxQII-KqP78b1EpiZJVUq4TEKSWtNSakmh8TyPFAEFsR_qpS8TFQT-kF3tfDe1_WzJNVGZu5iKwlRkWxehBikBdQ_iDoxr61xNabSp89LUXYQQfZcZ_Smz11zuzdtlScmvYt9eD4x2gDMZRWvb1lUf9h_HL8QzesE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18055018</pqid></control><display><type>article</type><title>Impact of 30-Day Oral Dosing with N-acetyl-l-cysteine on Sprague-Dawley Rat Physiology</title><source>MEDLINE</source><source>SAGE Complete</source><source>Alma/SFX Local Collection</source><creator>Arfsten, Darryl P. ; Johnson, Eric W. ; Thitoff, Angie R. ; Jung, Anne E. ; Wilfong, Erin R. ; Lohrke, Scott M. ; Bausman, Tim A. ; Eggers, Jeffrey S. ; Bobb, Andrew J.</creator><creatorcontrib>Arfsten, Darryl P. ; Johnson, Eric W. ; Thitoff, Angie R. ; Jung, Anne E. ; Wilfong, Erin R. ; Lohrke, Scott M. ; Bausman, Tim A. ; Eggers, Jeffrey S. ; Bobb, Andrew J.</creatorcontrib><description>A number of studies have demonstrated a protective effect associated with N-acetyl-l-cysteine (NAC) against toxic chemical exposure. However, the impact of long-term oral dosing on tissue pathology has not been determined. In this study, the authors assessed the impact of long-term oral NAC administration on organ histopathology and tissue glutathione (GSH) and total glutathione-S-transferase (GST) activity levels in Sprague-Dawley (SD) rats. Groups of 20 SD rats (10 males, 10 females), 8 weeks of age, were dosed daily by oral gavage with deionized H2O (negative controls) or NAC solution at a rate of 600 or 1200 mg/kg/day for 30 days. Animals were euthanized 6 h after treatment on study day 30. There were no significant differences in final body weights or weekly average weight gain between treatment groups. Serum alanine amino-transferase (ALT) activities were significantly elevated (p ≤.05) in NAC-treated animals compared to controls when measured on study day 30. Histopathologic evaluation of the stomach, small intestine, liver, kidneys, spleen, thymus, and lungs revealed no lesions associated with NAC administration. When measured on study day 30, total GST activity for kidney and skin from NAC-treated animals were increased 39% to 131% as compared to controls. Tissue GSH concentrations from NAC-treated animals were increased 24% to 81% as compared with negative controls. Further studies are needed to determine if the observed increase in tissue GSH concentration and GST activity provide a degree of chemoprotection against dermal and systemic chemical toxicants.</description><identifier>ISSN: 1091-5818</identifier><identifier>EISSN: 1092-874X</identifier><identifier>DOI: 10.1080/10915810490502041</identifier><identifier>PMID: 15371168</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Acetylcysteine - administration &amp; dosage ; Acetylcysteine - toxicity ; Alanine Transaminase - blood ; Animals ; Antidotes - administration &amp; dosage ; Antidotes - toxicity ; Dose-Response Relationship, Drug ; Female ; Glutathione - metabolism ; Glutathione Transferase - metabolism ; Kidney - drug effects ; Kidney - enzymology ; Male ; Rats ; Rats, Sprague-Dawley ; Skin - drug effects ; Skin - enzymology ; Toxicity Tests</subject><ispartof>International journal of toxicology, 2004-07, Vol.23 (4), p.239-247</ispartof><rights>Copyright © American College of Toxicology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c367t-a570400d1317a87a832d5fadf7fe1bd9e588eb585e9a222e7e0e6c398b35d7663</citedby><cites>FETCH-LOGICAL-c367t-a570400d1317a87a832d5fadf7fe1bd9e588eb585e9a222e7e0e6c398b35d7663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1080/10915810490502041$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1080/10915810490502041$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15371168$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arfsten, Darryl P.</creatorcontrib><creatorcontrib>Johnson, Eric W.</creatorcontrib><creatorcontrib>Thitoff, Angie R.</creatorcontrib><creatorcontrib>Jung, Anne E.</creatorcontrib><creatorcontrib>Wilfong, Erin R.</creatorcontrib><creatorcontrib>Lohrke, Scott M.</creatorcontrib><creatorcontrib>Bausman, Tim A.</creatorcontrib><creatorcontrib>Eggers, Jeffrey S.</creatorcontrib><creatorcontrib>Bobb, Andrew J.</creatorcontrib><title>Impact of 30-Day Oral Dosing with N-acetyl-l-cysteine on Sprague-Dawley Rat Physiology</title><title>International journal of toxicology</title><addtitle>Int J Toxicol</addtitle><description>A number of studies have demonstrated a protective effect associated with N-acetyl-l-cysteine (NAC) against toxic chemical exposure. However, the impact of long-term oral dosing on tissue pathology has not been determined. In this study, the authors assessed the impact of long-term oral NAC administration on organ histopathology and tissue glutathione (GSH) and total glutathione-S-transferase (GST) activity levels in Sprague-Dawley (SD) rats. Groups of 20 SD rats (10 males, 10 females), 8 weeks of age, were dosed daily by oral gavage with deionized H2O (negative controls) or NAC solution at a rate of 600 or 1200 mg/kg/day for 30 days. Animals were euthanized 6 h after treatment on study day 30. There were no significant differences in final body weights or weekly average weight gain between treatment groups. Serum alanine amino-transferase (ALT) activities were significantly elevated (p ≤.05) in NAC-treated animals compared to controls when measured on study day 30. Histopathologic evaluation of the stomach, small intestine, liver, kidneys, spleen, thymus, and lungs revealed no lesions associated with NAC administration. When measured on study day 30, total GST activity for kidney and skin from NAC-treated animals were increased 39% to 131% as compared to controls. Tissue GSH concentrations from NAC-treated animals were increased 24% to 81% as compared with negative controls. Further studies are needed to determine if the observed increase in tissue GSH concentration and GST activity provide a degree of chemoprotection against dermal and systemic chemical toxicants.</description><subject>Acetylcysteine - administration &amp; dosage</subject><subject>Acetylcysteine - toxicity</subject><subject>Alanine Transaminase - blood</subject><subject>Animals</subject><subject>Antidotes - administration &amp; dosage</subject><subject>Antidotes - toxicity</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Glutathione - metabolism</subject><subject>Glutathione Transferase - metabolism</subject><subject>Kidney - drug effects</subject><subject>Kidney - enzymology</subject><subject>Male</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Skin - drug effects</subject><subject>Skin - enzymology</subject><subject>Toxicity Tests</subject><issn>1091-5818</issn><issn>1092-874X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1Lw0AQxRdRrFb_AC-yJ29bZ5JudnOU1o9CseIX3sI2maQpSbZmE0r-e6MteBCEgRmG33vwHmMXCCMEDdcIIUqNMA5BggdjPGAn_c8TWo0_Dn9uFD2gB-zUuTUABEriMRug9BVioE_Y-6zcmLjhNuU-iKnp-KI2BZ9al1cZ3-bNij8KE1PTFaIQcecayivituIvm9pkLfWabUEdfzYNf1p1LreFzbozdpSawtH5fg_Z293t6-RBzBf3s8nNXMR-oBphpIIxQII-KqP78b1EpiZJVUq4TEKSWtNSakmh8TyPFAEFsR_qpS8TFQT-kF3tfDe1_WzJNVGZu5iKwlRkWxehBikBdQ_iDoxr61xNabSp89LUXYQQfZcZ_Smz11zuzdtlScmvYt9eD4x2gDMZRWvb1lUf9h_HL8QzesE</recordid><startdate>200407</startdate><enddate>200407</enddate><creator>Arfsten, Darryl P.</creator><creator>Johnson, Eric W.</creator><creator>Thitoff, Angie R.</creator><creator>Jung, Anne E.</creator><creator>Wilfong, Erin R.</creator><creator>Lohrke, Scott M.</creator><creator>Bausman, Tim A.</creator><creator>Eggers, Jeffrey S.</creator><creator>Bobb, Andrew J.</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>200407</creationdate><title>Impact of 30-Day Oral Dosing with N-acetyl-l-cysteine on Sprague-Dawley Rat Physiology</title><author>Arfsten, Darryl P. ; Johnson, Eric W. ; Thitoff, Angie R. ; Jung, Anne E. ; Wilfong, Erin R. ; Lohrke, Scott M. ; Bausman, Tim A. ; Eggers, Jeffrey S. ; Bobb, Andrew J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c367t-a570400d1317a87a832d5fadf7fe1bd9e588eb585e9a222e7e0e6c398b35d7663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Acetylcysteine - administration &amp; dosage</topic><topic>Acetylcysteine - toxicity</topic><topic>Alanine Transaminase - blood</topic><topic>Animals</topic><topic>Antidotes - administration &amp; dosage</topic><topic>Antidotes - toxicity</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Glutathione - metabolism</topic><topic>Glutathione Transferase - metabolism</topic><topic>Kidney - drug effects</topic><topic>Kidney - enzymology</topic><topic>Male</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Skin - drug effects</topic><topic>Skin - enzymology</topic><topic>Toxicity Tests</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arfsten, Darryl P.</creatorcontrib><creatorcontrib>Johnson, Eric W.</creatorcontrib><creatorcontrib>Thitoff, Angie R.</creatorcontrib><creatorcontrib>Jung, Anne E.</creatorcontrib><creatorcontrib>Wilfong, Erin R.</creatorcontrib><creatorcontrib>Lohrke, Scott M.</creatorcontrib><creatorcontrib>Bausman, Tim A.</creatorcontrib><creatorcontrib>Eggers, Jeffrey S.</creatorcontrib><creatorcontrib>Bobb, Andrew J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>International journal of toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arfsten, Darryl P.</au><au>Johnson, Eric W.</au><au>Thitoff, Angie R.</au><au>Jung, Anne E.</au><au>Wilfong, Erin R.</au><au>Lohrke, Scott M.</au><au>Bausman, Tim A.</au><au>Eggers, Jeffrey S.</au><au>Bobb, Andrew J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of 30-Day Oral Dosing with N-acetyl-l-cysteine on Sprague-Dawley Rat Physiology</atitle><jtitle>International journal of toxicology</jtitle><addtitle>Int J Toxicol</addtitle><date>2004-07</date><risdate>2004</risdate><volume>23</volume><issue>4</issue><spage>239</spage><epage>247</epage><pages>239-247</pages><issn>1091-5818</issn><eissn>1092-874X</eissn><abstract>A number of studies have demonstrated a protective effect associated with N-acetyl-l-cysteine (NAC) against toxic chemical exposure. However, the impact of long-term oral dosing on tissue pathology has not been determined. In this study, the authors assessed the impact of long-term oral NAC administration on organ histopathology and tissue glutathione (GSH) and total glutathione-S-transferase (GST) activity levels in Sprague-Dawley (SD) rats. Groups of 20 SD rats (10 males, 10 females), 8 weeks of age, were dosed daily by oral gavage with deionized H2O (negative controls) or NAC solution at a rate of 600 or 1200 mg/kg/day for 30 days. Animals were euthanized 6 h after treatment on study day 30. There were no significant differences in final body weights or weekly average weight gain between treatment groups. Serum alanine amino-transferase (ALT) activities were significantly elevated (p ≤.05) in NAC-treated animals compared to controls when measured on study day 30. Histopathologic evaluation of the stomach, small intestine, liver, kidneys, spleen, thymus, and lungs revealed no lesions associated with NAC administration. When measured on study day 30, total GST activity for kidney and skin from NAC-treated animals were increased 39% to 131% as compared to controls. Tissue GSH concentrations from NAC-treated animals were increased 24% to 81% as compared with negative controls. Further studies are needed to determine if the observed increase in tissue GSH concentration and GST activity provide a degree of chemoprotection against dermal and systemic chemical toxicants.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>15371168</pmid><doi>10.1080/10915810490502041</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1091-5818
ispartof International journal of toxicology, 2004-07, Vol.23 (4), p.239-247
issn 1091-5818
1092-874X
language eng
recordid cdi_proquest_miscellaneous_18055018
source MEDLINE; SAGE Complete; Alma/SFX Local Collection
subjects Acetylcysteine - administration & dosage
Acetylcysteine - toxicity
Alanine Transaminase - blood
Animals
Antidotes - administration & dosage
Antidotes - toxicity
Dose-Response Relationship, Drug
Female
Glutathione - metabolism
Glutathione Transferase - metabolism
Kidney - drug effects
Kidney - enzymology
Male
Rats
Rats, Sprague-Dawley
Skin - drug effects
Skin - enzymology
Toxicity Tests
title Impact of 30-Day Oral Dosing with N-acetyl-l-cysteine on Sprague-Dawley Rat Physiology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T00%3A51%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%2030-Day%20Oral%20Dosing%20with%20N-acetyl-l-cysteine%20on%20Sprague-Dawley%20Rat%20Physiology&rft.jtitle=International%20journal%20of%20toxicology&rft.au=Arfsten,%20Darryl%20P.&rft.date=2004-07&rft.volume=23&rft.issue=4&rft.spage=239&rft.epage=247&rft.pages=239-247&rft.issn=1091-5818&rft.eissn=1092-874X&rft_id=info:doi/10.1080/10915810490502041&rft_dat=%3Cproquest_cross%3E18055018%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18055018&rft_id=info:pmid/15371168&rft_sage_id=10.1080_10915810490502041&rfr_iscdi=true